申请人:ELI LILLY AND COMPANY
公开号:EP0438869A1
公开(公告)日:1991-07-31
This invention provides phenyl and heterocyclic derivatives of the formula
or a pharmaceutically acceptable salt or solvate thereof where G is
Aris
each of A1, A2, and A3 is independently N or CH;
X is -CO-, -CONH-, -NHCO-, -CH2 CONH-, -O-, -NH-, -CH2-each R1 is independently - (CH2)nR3;
R2 is C4-C7 straight chain alkyl;
each R3 is independently -OH, -COOH, or 5-tetrazolyl;
each n is independently 0, 1, 2, 3, or 4;
R4 is H, OH, halo, nitro, methyl, amino, acetamido, or methanesulfonamido;
Q is a bond or -O-; and
w is H, methyl, ethyl, or hydroxy.
Their pharmaceutical formulations and their use for antagonizing angiotensin II receptors in mammals.
本发明提供了式中的苯基和杂环衍生物
或其药学上可接受的盐或溶液 其中 G 为
亚里士
A1、A2 和 A3 各自独立地为 N 或 CH;
X 是-CO-、-CONH-、-NHCO-、-CH2 CONH-、-O-、-NH-、-CH2-每个 R1 独立地是-(CH2)nR3;
R2 是 C4-C7 直链烷基;
每个 R3 独立地为-OH、-COOH 或 5-四唑基;
每个 n 独立地为 0、1、2、3 或 4;
R4 是 H、OH、卤代、硝基、甲基、氨基、乙酰胺基或甲磺酰胺基;
Q 是键或-O-;以及
w 是 H、甲基、乙基或羟基。
它们的药物制剂及其在哺乳动物体内拮抗血管紧张素 II 受体的用途。